alloshrink: phase i first-in-human study evaluating cyad-101, an allogeneic car-t in mcrc
Published 3 years ago • 106 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
3:24
cyad-101 & alloshrink: allogeneic car-t cell therapy in mss mcrc
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
2:04
rna sequencing of single allergen-specific memory b cells after grass pollen immunotherapy
-
2:39
how is io changing cancer treatment
-
1:01
every child, every step of the way
-
10:47
ac22 - investigating the role of yap1 signaling in shaping the tumor immune landscape of icca
-
1:23
ascend-1 and ascend-2: ceritinib for alk-rearranged nsclc and baseline brain metastases
-
1:01
improving the efficacy of immunotherapy using anti-angiogenic agents in gi malignancies
-
5:57
prognostic value of circulating tumour-cell count in metastatic breast cancer patients
-
2:53
the origins of kif1a.org
-
2:54
asco gi 2021: biomarker-driven research, radiomics & car-t
-
2:37
kcnma1-linked channelopathy explained
-
1:19
asco22 metastatic breast cancer updates | sramila aithal, md | us oncology
-
5:38
therapeutic options at progression of alk-rearranged nsclc
-
5:49
diagnosing polyps: can cadx provide the same accuracy as endoscopists?
-
1:29
dr. kris on integrating multicenter mutation testing study results
-
6:13
laparoscopic total mesorectal excision with coloanal anastomosis in an adolescent female with sp...
-
1:30
real-time immune cell killing of 3d tumor spheroid assays using xcelligence rtca esight